2020
DOI: 10.1186/s12933-020-01018-3
|View full text |Cite
|
Sign up to set email alerts
|

Retinopathy predicts stroke but not myocardial infarction in type 2 diabetes: the Fremantle Diabetes Study Phase II

Abstract: Background: Microangiopathy in type 2 diabetes (T2D) is associated with cardiovascular disease (CVD), but most relevant studies were performed > 10 years ago. CVD risk factor management has since improved. The aim of this study was to determine whether diabetic retinopathy (DR) and its severity increases stroke and myocardial infarction (MI) risk in a contemporary cohort. Methods: Fremantle Diabetes Study Phase II participants with T2D had DR graded from fundus photography at baseline between 2008 and 2011. Su… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
28
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(29 citation statements)
references
References 45 publications
1
28
0
Order By: Relevance
“…They assumed the correlation between DR and CHD may be due to similar pathophysiological backgrounds. Drinkwater et al [ 22 ] also claimed the intensified CVD risk factor management should be considered for patients with at least moderate NPDR. However, the Age, Gene/Environment Susceptibility-Reykjavik Study (AGES-RS) explores the impact of retinopathy on mortality, and declares even minimal retinopathy is a significant predictor of increased mortality in older persons, irrespective of diabetes status [ 23 ].…”
Section: Discussionmentioning
confidence: 99%
“…They assumed the correlation between DR and CHD may be due to similar pathophysiological backgrounds. Drinkwater et al [ 22 ] also claimed the intensified CVD risk factor management should be considered for patients with at least moderate NPDR. However, the Age, Gene/Environment Susceptibility-Reykjavik Study (AGES-RS) explores the impact of retinopathy on mortality, and declares even minimal retinopathy is a significant predictor of increased mortality in older persons, irrespective of diabetes status [ 23 ].…”
Section: Discussionmentioning
confidence: 99%
“…Since no reply was received from the authors of two studies (20, 21) after three contact attempts, and the author of one study (22) replied that they did not have the resources at that time to rerun the models, these three publications have been excluded. Finally, 19 studies (23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40)(41) were included in the present meta-analysis.…”
Section: Literature Search and Selection Resultsmentioning
confidence: 99%
“…Among these studies, the fraction of males per studies varied from 37.9 to 77.1%. Ten studies ( 26 , 27 , 32 36 , 38 41 ) included only T2DM patients, one study ( 28 ) included only T1DM patients, and the remaining eight studies ( 23 25 , 29 31 , 37 ) included patients with both types of diabetes.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…They assumed the correlation between DR and CHD may be due to similar pathophysiological backgrounds. Drinkwater et al [22] also claimed the intensi ed CVD risk factor management should be considered for patients with at least moderate NPDR. However, the Age, Gene/Environment Susceptibility-Reykjavik Study (AGES-RS) explores the impact of retinopathy on mortality, and declares even minimal retinopathy is a signi cant predictor of increased mortality in older persons, irrespective of diabetes status [23].…”
Section: Discussionmentioning
confidence: 99%